US-based Mass General Cancer Center is set to expand the use of RayStation, an advanced cancer treatment planning system developed by RaySearch Laboratories, to proton treatment planning.
Mass General Cancer Center is claimed to be the first in the world to provide proton therapy, and currently, it is in the process of transitioning its proton treatment planning system to RayStation.
Claimed to be a flexible cancer treatment planning system, RayStation come with features for proton therapy planning such as multi-criteria optimisation, LET analysis, and optimisation, as well as has modalities under development such as proton arcs.
This cancer centre has been leveraging RayStation for photon radiation therapy planning for over a decade. By boosting its clinical use to include protons, all external beam planning can now be undertaken by the centre on one platform.
Mass General Cancer Center physics research in radiation oncology director Harald Paganetti said: “We have had access to RayStation for many years, and my team and I are pleased that the system soon will be used clinically for proton planning as well as.
“This will expedite the translation of research findings and new technologies into the clinic.”
Besides offering adaptive therapy capabilities, multi-criteria optimisation, algorithms for treatment plan optimisation for HDR brachytherapy and external beam therapy with photons, electrons, and protons, helium and carbon ions, RayStation supports several treatment equipment, thereby providing one control centre for all treatment planning needs.
RaySearch founder and CEO Johan Löf said: “Mass General is truly a pioneering collaboration partner to RaySearch.
“They were one of the very first users of RayStation in the world and we have benefitted greatly from various collaboration projects that we have done together during the years.
“I am happy that they now have the opportunity to start using RayStation also for their proton treatments.”
